Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details Narrative)

NOTES PAYABLE (Details Narrative)				1 Months Ended																	2 Months Ended	3 Months Ended		9 Months Ended
NOTES PAYABLE (Details Narrative)	Apr. 01, 2023 USD ($) shares	Aug. 15, 2022 USD ($)	Feb. 09, 2021 USD ($) $ / shares	Sep. 30, 2024 USD ($) $ / shares	Aug. 31, 2024 USD ($)	May 31, 2024 USD ($)	Apr. 30, 2024 USD ($) shares	Mar. 31, 2024 USD ($) $ / shares	Feb. 29, 2024 USD ($)	Nov. 30, 2023 USD ($)	Oct. 31, 2023 USD ($)	Sep. 30, 2023 USD ($) $ / shares	Jul. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)	May 31, 2023 USD ($)	Mar. 31, 2023 USD ($)	Jan. 31, 2023 USD ($) shares	Dec. 31, 2022 USD ($)	Aug. 31, 2022 USD ($)	Jul. 31, 2022 USD ($)	Mar. 31, 2024 USD ($) $ / shares	Sep. 30, 2024 USD ($) $ / shares	Sep. 30, 2023 USD ($) $ / shares	Sep. 30, 2024 USD ($) $ / shares	Sep. 30, 2023 USD ($) $ / shares	Mar. 05, 2024 USD ($)	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Weighted-average stated annual interest rate				13.00%																		13.00%		13.00%			12.00%
Weighted-average effective annual interest rate				14.00%																		14.00%		14.00%			23.00%
Proceeds from convertible notes payable issued																									$ 1,000,000
Interest rate				2.00%																		2.00%		2.00%
Gain (loss) on debt extinguishment																						$ 0	$ (647,000)	$ 0	(647,000)
Gain on restructured debt																								1,032,000
Issuance cost																				$ 32,000
Fair value of warrants																				$ 84,000
Common stock				$ 64,000																		64,000		64,000			$ 62,000
Fair value of the conversion feature				$ 0																		$ 0		$ 0		$ 2,000
Purchased Amount [Member]
Debt Instrument [Line Items]
Gain (loss) on debt extinguishment												$ (312,000)
Hope International Hospice, Inc. [Member]
Debt Instrument [Line Items]
Principal amount		$ 50,000														$ 100,000
Interest rate		10.00%														10.00%
Prepayment amount		$ 1,924,819
Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Conversion price \| $ / shares								$ 0.13													$ 0.13
Interest rate								10.00%													10.00%
Business Loan and Security Agreement [Member]
Debt Instrument [Line Items]
Principal amount												2,200,000											2,200,000		2,200,000
Net proceeds												$ 2,100,000
Promissory Notes [Member]
Debt Instrument [Line Items]
Principal amount	$ 1,000,000
Shares converted into common stock \| shares	2,702,702
Interest rate																			10.00%	12.00%
Debt instrument, maturity date																			Aug. 16, 2027	Jul. 31, 2027
Promissory Notes [Member] \| Unaffiliated Third Parties [Member]
Debt Instrument [Line Items]
Principal amount																			$ 1,668,751	$ 402,000
Promissory Notes [Member] \| Personal Funds [Member]
Debt Instrument [Line Items]
Principal amount																			250,000
Demand Promissory Notes [Member]
Debt Instrument [Line Items]
Principal amount									$ 2,800,000
Dr. Niihara and His Wife [Member]
Debt Instrument [Line Items]
Principal amount																$ 127,000
Interest rate																10.00%
Dr. Niihara and His Wife [Member] \| Promissory Notes [Member]
Debt Instrument [Line Items]
Principal amount																			$ 1,576,574	$ 370,000
Wei Pei Zen [Member]
Debt Instrument [Line Items]
Principal amount																											$ 700,000
Interest rate																											5.00%
Debt instrument, loan repaid									350,000
Wei Pei Zen [Member] \| Smart Start Investments Limited [Member]
Debt Instrument [Line Items]
Principal amount								$ 1,400,000													$ 1,400,000
Interest rate								2.50%													2.50%
Default percentage of interest rate						0.05
Percentage of shareholding ownership held								9.96%				9.96%
Wei Pei Zen [Member] \| Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Principal amount												$ 1,000,000											$ 1,000,000		$ 1,000,000
Conversion price \| $ / shares												$ 0.29											$ 0.29		$ 0.29
Interest rate												10.00%											10.00%		10.00%
Debt instrument, maturity date												Sep. 05, 2024
Securities Purchase Agreement [Member] \| Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Principal amount							$ 260,000										$ 500,000
Shares converted into common stock \| shares							2,019,608										1,351,351
Proceeds from convertible notes payable issued			$ 14,500,000
Conversion price \| $ / shares			$ 1.48	$ 0.09																		$ 0.09		$ 0.09
Debt instrument, frequency of periodic payment			The convertible promissory notes bear interest at the rate of 2% per year, payable semi-annually on the last business day of August and January of each year and will mature on the 3rd anniversary of the original issue date, unless earlier converted or prepaid.
Interest rate			2.00%
Amount of principal repaid				$ 50,000	$ 75,000				$ 200,000
Securities Purchase Agreement [Member] \| Maximum [Member] \| Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Principal amount			$ 17,000,000
Purchase and Sales of Future Receipts [Member]
Debt Instrument [Line Items]
Installment payment																		$ 103,500
Purchase and Sales of Future Receipts [Member] \| Purchased Amount [Member]
Debt Instrument [Line Items]
Sale of accounts receivable																		3,105,000
Proceeds from sale of notes receivable																		$ 2,300,000
Revenue Purchase Agreement [Member]
Debt Instrument [Line Items]
Gain (loss) on debt extinguishment													$ (81,000)		$ (43,000)
Sale of accounts receivable				1,298,000		$ 1,628,000				$ 762,200	$ 1,377,500		828,000		528,200	$ 700,212
Proceeds from sale of notes receivable				800,000		1,001,000				468,650	875,000		300,000		368,600	$ 491,933
Amount agreed to pay weekly sales receipts until future receipt is delivered						$ 58,143				$ 49,000	$ 81,000		26,000		$ 19,000
Amount agreed to pay weekly sales receipts				$ 35,000
Term of Notes				70 days
Amount agreed to pay weekly sales receipts thereafter until future receipt is delivered				$ 41,217
Percentage of amount agreed to pay weekly until future receipt is delivered																4.00%
Repayments of notes payable indebtedness													204,000
Revenue Beased Financing Agreement [Member]
Debt Instrument [Line Items]
Gain (loss) on debt extinguishment													(87,000)
Sale of accounts receivable													828,000			$ 700,212
Proceeds from sale of notes receivable													276,000			492,132
Amount agreed to pay weekly sales receipts until future receipt is delivered													26,000			$ 22,000
Repayments of notes payable indebtedness													$ 222,000
Standard Merchant Cash Advance Agreement [Member]
Debt Instrument [Line Items]
Gain (loss) on debt extinguishment														$ (124,000)
Sale of accounts receivable														877,560
Proceeds from sale of notes receivable														600,000
Amount agreed to pay weekly sales receipts until future receipt is delivered														$ 34,000
Exchange Agreement [Member] \| Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Principal amount								$ 11,100,000													$ 11,100,000
Maturity year																					2024
Conversion price \| $ / shares								$ 0.13													$ 0.13
Interest rate								2.00%													2.00%
Gain on restructured debt																								$ 1,000,000